Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels.
William U. Shipley
No relevant relationships to disclose
Daniel Hunt
No relevant relationships to disclose
Himu R. Lukka
No relevant relationships to disclose
Pierre Major
No relevant relationships to disclose
Niall M. Heney
No relevant relationships to disclose
David Grignon
No relevant relationships to disclose
Maltibehn Patel
No relevant relationships to disclose
Jean-Paul Bahary
No relevant relationships to disclose
Colleen Anne Lawton
No relevant relationships to disclose
Howard Mark Sandler
No relevant relationships to disclose